Quarterly report pursuant to Section 13 or 15(d)

Net Loss per Share (Tables)

v3.22.2.2
Net Loss per Share (Tables)
9 Months Ended
Sep. 30, 2022
Earnings Per Share [Abstract]  
Schedule of basic and diluted net income (loss) per share
Basic and diluted net loss per share attributable to common stockholders was calculated as follows (in thousands, except share and per share amounts):
Three Months Ended September 30, Nine Months Ended September 30,
2022 2021 2022 2021
Numerator:
Net income (loss) attributable to common stockholders – basic $ (18,615) $ 20,807  $ (58,102) $ (15,676)
Change in fair value for warrant liability (42)
Interest to convertible notes 123
Loss on extinguishment of debt 865
Change in fair value of derivative liability (475)
Net income (loss) attributable to common stockholders – diluted $ (18,615) $ 21,278  $ (58,102) $ (15,676)
Denominator:
Weighted average common shares outstanding – basic 144,117,273 119,745,196 143,522,555 47,772,253
Weighted average effect of potentially dilutive securities:
Effect of potentially dilutive convertible preferred stock 14,065,012
Effect of potentially dilutive warrants 423,271
Effect of potentially dilutive stock options 19,696,440
Effect of potentially dilutive restricted stock units 6,517
Total potentially dilutive securities 34,191,240
Weighted average common shares outstanding — diluted 144,117,273 153,936,436 143,522,555 47,772,253
Net income (loss) per share attributable to common stockholders - basic $ (0.13) $ 0.17 $ (0.40) $ (0.33)
Net income (loss) per share attributable to common stockholders - diluted $ (0.13) $ 0.14 $ (0.40) $ (0.33)
Schedule of potential common shares excluded from the computation of diluted net loss per share
The following potentially dilutive outstanding securities were excluded from the computation of diluted net loss per share attributable to common stockholders because their effect would have been anti-dilutive or issuance of such shares is contingent upon the satisfaction of certain conditions which were not satisfied by the end of the period:
Three Months Ended
September 30,
Nine Months Ended
September 30,
2022 2021 2022 2021
Options issued and outstanding 21,027,840 1,589,357  21,027,840 21,285,797 
Public Warrants to purchase common stock 14,324,994  14,325,000  14,324,994  14,325,000 
Warrants to purchase common stock (Finback)*** 2,552,913  2,214,879  2,552,913  2,552,913 
Unvested restricted stock units 7,336,179  1,664,567  7,336,179  1,671,084 
Unvested performance stock units 889,000  —  889,000  — 
Earn-out shares** 15,000,000  15,000,000  15,000,000  15,000,000 
Contingently issuable common stock** 1,897,500  1,897,500  1,897,500  1,897,500 
Convertible notes (as converted to common stock)* —  5,408,672  —  5,408,672 
63,028,426  42,099,975  63,028,426  62,140,966 
*Conversion feature is only triggered upon the closing of a Qualified Financing Event
**Issuance of Earn-out shares and Contingently issuable common stock are contingent upon the satisfaction of certain conditions, which were not satisfied by the end of the period
***Includes 700,575 vested warrants and 1,852,338 unvested warrants as of September 30, 2022